Menard Francois A 4
4 · WATSON PHARMACEUTICALS INC · Filed Feb 22, 2012
Insider Transaction Report
Form 4
Menard Francois A
SVP,Generics R&D
Transactions
- Tax Payment
Common Stock, par value $0.0033
2012-02-19$60.18/sh−1,157$69,628→ 34,750 total
Footnotes (1)
- [F1]Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.